Scarica l'app Stockscreener
5.565
2.49%
0.135
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
A 1:30 p.m. Pacific call will cover Cytek's third-quarter results on Nov. 4. - Stock Titan
Cytek Biosciences Stock Price Forecast. Should You Buy CTKB? - StockInvest.us
Cytek Biosciences (NASDAQ:CTKB) Updates Bylaws Following $56.1 Million Patent Verdict - Kalkine Media
Form 8K Cytek Biosciences Inc For: 29 September By Investing.com - Investing.com India
Form 8K Cytek Biosciences Inc For: 29 September By Investing.com - Investing.com Nigeria
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability - finance.yahoo.com
A new tool lets researchers analyze cell data online without rebuilding their work - Stock Titan
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Cytek Biosciences stock trades near recent lows after valuation update - AD HOC NEWS
Cytek Biosciences stock edges higher after recent earnings and analyst interest - AD HOC NEWS
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock? - Eastern Progress
3 Promising Penny Stocks With Market Caps Over $100M - Simply Wall Street
Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows - marketscreener.com
Sysmex Europe SE And Cytek Biosciences, Inc Collaborate To Expand Access To Advanced Clinical Flow Cytometry - marketscreener.com
Sysmex Europe SE and Cytek Biosciences Announce Strategic Collaboration to Expand Clinical Flow Cytometry Access Across Europe - Quiver Quantitative
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry - Yahoo Finance
European labs can combine routine testing with advanced leukemia and lymphoma analysis - Stock Titan
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing - Yahoo Finance
Cytek Biosciences to Showcase Spectral Flow Cytometry Solutions at ESCCA 2026 and ICCS 2026 - Quiver Quantitative
Cytek Biosciences Showcases Advanced Spectral Flow Cytometry Solutions At Escca and Iccs - marketscreener.com
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS - Yahoo Finance
Cytek Biosciences (CTKB) officer plans $146K share sale - Stock Titan
Cytek Biosciences stock holds near recent levels as investor conferences approach - AD HOC NEWS
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Owes Beckman Coulter $56 Million at Patent Jury Trial (2) - Bloomberg Law News
Cytek Biosciences Shares Drop After Jury Says It Owes $56 Million in Damages - marketscreener.com
Cytek (CTKB) Earnings Report: EPS Clears the Reported Estimate in Latest Trading; Price Reaction: Shares Finish 3.22% Up in the Latest SessionPre-Announcement Alert - vinanet.vn
Cytek Hit With $56M Verdict For Infringing Cell-Sorting Patent - Law360
Cytek Biosciences wins on three of four patent claims - Investing.com
Cytek Biosciences wins on three of four patent claims By Investing.com - Investing.com Nigeria
Cytek Biosciences wins on three of four patent claims By Investing.com - Investing.com Canada
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding - marketscreener.com
Cytek products remain available worldwide after jury awards $36M in royalties - Stock Titan
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says - Reuters
Cytek Biosciences CFO William D. McCombe Executes RSU Vesting and Tax Withholding Transactions - Kalkine Media
Cytek Biosciences Director Glenn P. Muir Converts 3,086 RSUs to Common Stock on August 18, 2026 - Kalkine Media
Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 3,086 no-cost shares - Stock Titan
Cytek Biosciences (CTKB) director now holds 28,499 shares - Stock Titan
Cytek Biosciences (CTKB) CTO gets 33,270 shares, surrenders some for taxes - Stock Titan
Cytek (CTKB) Quarterly Figures: EPS Prints Above Forecast in the Latest Session; Stock Move: Shares Finish 0.96% HigherEstimate Dispersion - vinanet.vn
Cytek Biosciences CEO Wenbin Jiang Completes RSU Vesting and Tax Withholding Share Surrender - Kalkine Media
Cytek Biosciences Balances Growth With Profit Pressures - TipRanks
Actelis Networks Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
Cytek (CTKB) Q2 2026 Earnings Call Transcript - AOL.com
Cytek Biosciences (CTKB) awards 241,416 RSUs and 127,118 options to top lawyer - Stock Titan
Cytek (CTKB) Q2 2026 Earnings Call Transcript - The Globe and Mail
Cytek Biosciences: Recurring Revenue Reaches 35% Of Sales As Installed Base Approaches 4,000 Instruments - Pulse 2.0
Cytek Biosciences launches Aurora Evo system to drive high-throughput research and small particle detection - Traders Union
Promising Penny Stocks To Consider In August 2026 - simplywall.st
0.03%
2.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):